Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case–control study, Spain, 2023/24 seasonOlivier Núñez, Sergio Fernández Martínez, Pedro Eliseo Pastor Villalba et al.|Eurosurveillance|2025Cited by 25
Influenza vaccine effectiveness in Europe and the birth cohort effect against influenza A(H1N1)pdm09: VEBIS primary care multicentre study, 2023/24Esther Kissling, Marine Maurel, Francisco Pozo et al.|Eurosurveillance|2025Cited by 9
Nirsevimab Effectiveness Against Rsv Hospital Admission in Children Under 1 Year of Age: A Spanish Population-Based Case Control StudyOlivier Núñez, Susana Monge, Carmen Olmedo et al.|SSRN Electronic Journal|2024Cited by 4